Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes
Author:
Funder
Guangdong Innovative and Entrepreneurial Research Team Program
Natural Science Foundation of Guangdong Province
Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference39 articles.
1. Type 2 diabetes: principles of pathogenesis and therapy;Stumvoll;Lancet,2005
2. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes;Nauck;Exp. Clin. Endocrinol. Diabetes,1997
3. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007
4. Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study;Grunberger;Diabet. Med.,2012
5. Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ultrasmall iridium-encapsulated porphyrin metal-organic frameworks for enhanced photodynamic/catalytic therapy by producing reactive oxygen species storm;Journal of Colloid and Interface Science;2025-01
2. Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation;CHINESE CHEM LETT;2024
3. Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation;Chinese Chemical Letters;2024-10
4. Antibacterial adhesive based on oxidized tannic acid-chitosan for rapid hemostasis;Carbohydrate Polymers;2024-06
5. Enhancing the Therapeutic Efficacy of GLP-1 for Hyperglycemia Treatment: Overcoming Barriers of Oral Gene Therapy with Taurocholic Acid-Conjugated Protamine Sulfate and Calcium Phosphate;ACS Nanoscience Au;2024-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3